Faslodex (Fulvestrant) is a treatment for estrogen receptor-positive breast cancer in postmenopausal women whose cancer has progressed after treatment with antiestrogen therapy such as tamoxifen. Here are some details:

Common Side Effects
- Injection site pain
- Nausea
- Bone pain
- Joint pain
- Headache
- Back pain
- Show Full Answer

Faslodex (Fulvestrant) is a treatment for estrogen receptor-positive breast cancer in postmenopausal women whose cancer has progressed after treatment with antiestrogen therapy such as tamoxifen. Here are some details:

Common Side Effects:
- Injection site pain
- Nausea
- Bone pain
- Joint pain
- Headache
- Back pain
- Fatigue
- Pain in the extremities
- Hot flashes
- Vomiting
- Decreased appetite
- Weakness
- Musculoskeletal pain
- Cough
- Indigestion
- Constipation

Serious Side Effects:
- Fetal harm in pregnant people
- Bleeding disorders
- Liver impairment

Administration:
- Taken as an intramuscular injection
- Initial loading dose: three injections in the first month
- Maintenance dose: two injections once a month

For more information, you can visit:
- [Faslodex — BreastCancer.org](https://www.breastcancer.org/treatment/hormonal)
- [Faslodex — RxList](https://www.rxlist.com/faslodex-drug.htm)

If you have any specific concerns or symptoms, it's important to discuss them with your healthcare provider.

 This AI-generated response comes from MyBCTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Faslodex (Fulvestrant) for Breast Cancer | MyBCTeam

Femara (Letrozole) for Breast Cancer | MyBCTeam